Physician profile
Ross S Hendricks
NPI 1902272339
$2,743.09
in general payments reported to CMS, 2019-2025
16 companies · $731 in 2025
The $731 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $354 · 2022: $514 · 2023: $572 · 2024: $572 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,648 · Education: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,648.27 |
| Education | $226.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $612.73 | 2022-2025 | Opzelura, Opzelura |
| Abbvie INC. | $496.34 | 2021-2025 | |
| Genzyme Corporation | $327.00 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $257.51 | 2021-2025 | Dupixent |
| Janssen Biotech, INC. | $207.65 | 2021-2023 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $185.42 | 2022-2023 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $150.78 | 2022-2025 | |
| Organon LLC | $111.69 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $93.81 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $77.05 | 2024-2025 | Zoryve |
| Leo Pharma INC. | $66.26 | 2022-2024 | Adbry |
| Pfizer INC. | $60.24 | 2022 | |
| Allergan, INC. | $45.91 | 2022 | |
| Dermavant Sciences, INC. | $19.94 | 2024 | Vtama |
| Lilly USA, LLC | $17.84 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.